Artelo Biosciences, Inc. (ARTL)
3.11
-0.15
(-4.60%)
USD |
NASDAQ |
Oct 12, 16:00
3.10
-0.01
(-0.32%)
After-Hours: 20:00
Artelo Biosciences Price to Book Value : 2.607 for Oct. 12, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 12, 2026 | 2.607 |
| October 09, 2026 | 2.732 |
| October 08, 2026 | 2.825 |
| October 07, 2026 | 2.858 |
| October 06, 2026 | 2.900 |
| October 05, 2026 | 2.942 |
| October 02, 2026 | 3.084 |
| October 01, 2026 | 3.210 |
| September 30, 2026 | 3.386 |
| September 29, 2026 | 3.411 |
| September 28, 2026 | 3.604 |
| September 25, 2026 | 3.805 |
| September 24, 2026 | 4.333 |
| September 23, 2026 | 6.127 |
| September 22, 2026 | 3.478 |
| September 21, 2026 | 3.436 |
| September 18, 2026 | 3.302 |
| September 17, 2026 | 3.328 |
| September 16, 2026 | 3.143 |
| September 15, 2026 | 4.476 |
| September 14, 2026 | 4.082 |
| September 11, 2026 | 4.551 |
| September 10, 2026 | 4.719 |
| September 09, 2026 | 5.012 |
| September 08, 2026 | 5.188 |
| Date | Value |
|---|---|
| September 04, 2026 | 5.063 |
| September 03, 2026 | 5.214 |
| September 02, 2026 | 5.465 |
| September 01, 2026 | 5.159 |
| August 31, 2026 | 5.331 |
| August 28, 2026 | 4.999 |
| August 27, 2026 | 4.986 |
| August 26, 2026 | 5.360 |
| August 25, 2026 | 5.410 |
| August 24, 2026 | 5.198 |
| August 21, 2026 | 5.220 |
| August 20, 2026 | 5.374 |
| August 19, 2026 | 5.431 |
| August 18, 2026 | 5.506 |
| August 17, 2026 | 5.439 |
| August 14, 2026 | 5.961 |
| August 13, 2026 | 5.723 |
| August 12, 2026 | 5.530 |
| August 11, 2026 | 5.618 |
| August 10, 2026 | 5.319 |
| August 07, 2026 | 5.439 |
| August 06, 2026 | 5.676 |
| August 05, 2026 | 5.668 |
| August 04, 2026 | 5.772 |
| August 03, 2026 | 5.603 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.831 |
| Corcept Therapeutics, Inc. | 18.53 |
| Veru, Inc. | 1.445 |
| Johnson & Johnson | 7.475 |
| Eli Lilly & Co. | 32.87 |
Price to Book Value Related Metrics
| Price | 3.11 |
| Earnings Yield | -739.0% |
| Market Cap | 13.03M |